acetaminophen has been researched along with oxyntomodulin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Marks, V; Morgan, L; Ranganath, L; Sedgwick, I; Wright, J | 1 |
Holst, JJ; Juntunen, KS; Liukkonen, KH; Mykkänen, HM; Niskanen, LK; Poutanen, KS | 1 |
Andersen, B; Bagger, JI; Hartmann, B; Holst, JJ; Knop, FK; Vilsbøll, T | 1 |
Kristensen, K; Langeskov, EK | 1 |
2 trial(s) available for acetaminophen and oxyntomodulin
Article | Year |
---|---|
Postprandial glucose, insulin, and incretin responses to grain products in healthy subjects.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Blood Glucose; Bread; Dietary Fiber; Fasting; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Insulin; Male; Neurotransmitter Agents; Peptide Fragments; Postprandial Period; Secale; Triticum | 2002 |
Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure.
Topics: Acetaminophen; Adolescent; Adult; Analgesics, Non-Narcotic; Appetite; Cross-Over Studies; Double-Blind Method; Drug Interactions; Eating; Energy Metabolism; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Infusions, Intravenous; Male; Oxygen Consumption; Oxyntomodulin; Rest; Young Adult | 2015 |
2 other study(ies) available for acetaminophen and oxyntomodulin
Article | Year |
---|---|
The ageing entero-insular axis.
Topics: Acetaminophen; Adult; Aged; Aging; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Intolerance; Humans; Insulin; Insulin Secretion; Peptide Fragments; Postmenopause; Premenopause; Risk Factors | 1998 |
Population pharmacokinetic of paracetamol and atorvastatin with co-administration of semaglutide.
Topics: Acetaminophen; Atorvastatin; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Hypoglycemic Agents | 2022 |